Quince Therapeutics, Inc. (NASDAQ:QNCX) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
Quince Therapeutics, Inc.'s stock currently trades at $0.27 with a market capitalization of $245.6M. The Healthcare company's stock moved following the disclosure.